Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2025-12-25 @ 10:22 PM
Study NCT ID:
NCT04836858
Status:
COMPLETED
Last Update Posted:
2024-06-20
First Post:
2021-03-24
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-20
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-13
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-24
First Submit QC Date:
None
Study First Post Date:
2021-04-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-12-05
Results First Submit QC Date:
None
Results First Post Date:
2024-05-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-17
Last Update Post Date:
2024-06-20
Last Update Post Date Type:
ACTUAL